NCT06149910View on ClinicalTrials.gov

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

December 1, 2026

Conditions
Multiple MyelomaMultiple Myeloma Without Mention of Remission
Interventions
OTHER

Multiple Myeloma Pathway

Use and adherence to a multiple myeloma pathway.

OTHER

All4Cure Platform

Participant in the All4Cure platform.

OTHER

Documentation Pathway

Use of multiple myeloma pathway through written documentation.

Trial Locations (1)

98126

RECRUITING

All4Cure, Seattle

Sponsors

Lead Sponsor

All4Cure
All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

All4Cure

INDUSTRY

NCT06149910 - Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter